Rhabdomyosarcoma
📧 Sign up to get email alerts when something new happens for Rhabdomyosarcoma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2026-04-24Clinical Trial Update: Risk-Adapted Focal Proton Beam Radiation and/or Surgery in Patients With Low, Intermediate and High Risk Rhabdomyosarcoma Receiving Standard or Intensified Chemotherapy [Phase 2]
Phase 2 clinical trial evaluating risk-adapted focal proton beam radiation and/or surgery combined with standard or intensified chemotherapy…
-
CLINICAL_TRIALS research · 2026-04-23Clinical Trial Update: Integration of Adaptive Proton Therapy in Pediatric Solid Tumors and Hodgkin's Lymphoma [NA]
An update on a clinical trial evaluating adaptive proton therapy for pediatric solid tumors and Hodgkin lymphoma. The trial is currently not…
-
CLINICAL_TRIALS research · 2026-04-23Clinical Trial Update: Tumor-Lymph Node Mapping
Clinical trial from the University of Rochester is actively recruiting to study tumor-lymph node mapping in pediatric solid tumors. The cond…
-
CLINICAL_TRIALS research · 2026-04-20Clinical Trial Update: Targeted Oligometastatic Radiation in Pediatric and Young Adult Patients With Soft Tissue and Bone Sarcoma [NA]
This clinical trial update notes that a study evaluating targeted oligometastatic radiation for pediatric and young adult patients with soft…
-
CLINICAL_TRIALS research · 2026-04-16Clinical Trial Update: VITAS: Atezolizumab in Combination With Chemotherapy for Pediatric Relapsed/Refractory Solid Tumors [Phase 1, Phase 2]
An ongoing Phase 1/2 clinical trial evaluates atezolizumab in combination with chemotherapy for pediatric relapsed or refractory solid tumor…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2026-04-15Clinical Trial Update: PEEL-224, Vincristine and Temozolomide in Pediatric Solid Tumors [Phase 1, Phase 2]
This clinical trial update indicates that the PEEL-224 study of vincristine and temozolomide for pediatric refractory or relapsed solid tumo…
-
CLINICAL_TRIALS research · 2026-04-15Clinical Trial Update: B7-H3-Specific Chimeric Antigen Receptor Autologous T-Cell Therapy for Pediatric Patients With Solid Tumors (3CAR) [Phase 1]
Phase 1 clinical trial update for a B7-H3–targeted autologous CAR-T cell therapy (3CAR) in pediatric solid tumors, currently recruiting.
-
CLINICAL_TRIALS research · 2026-04-15Clinical Trial Update: Vorinostat in Combination With Chemotherapy in Relapsed/Refractory Solid Tumors and CNS Malignancies [Phase 1]
Phase 1 trial at New York Medical College evaluating vorinostat in combination with chemotherapy for relapsed/refractory solid tumors and CN…
-
CLINICAL_TRIALS research · 2026-04-09Clinical Trial Update: Silmitasertib (CX-4945) in Combination With Chemotherapy for Relapsed Refractory Solid Tumors [Phase 1, Phase 2]
Clinical trial evaluating silmitasertib (CX-4945) in combination with chemotherapy for relapsed or refractory solid tumors; Phase 1 and Phas…
-
CLINICAL_TRIALS research · 2026-04-08Clinical Trial Update: my.naviGATE: A Guide to After-Treatment Effects for Adolescents and Young Adults [NA]
Overview of the my.naviGATE guide for after-treatment effects in adolescents and young adults with sarcoma and related cancers; the study is…
-
CLINICAL_TRIALS research · 2026-04-06Clinical Trial Update: Study of Autologous Tumor-Infiltrating Lymphocytes in Pediatric, Adolescent, and Young Adult Participants [Phase 1]
Phase 1 study evaluating autologous tumor-infiltrating lymphocytes in pediatric, adolescent, and young adult participants with soft tissue s…
-
CLINICAL_TRIALS research · 2026-04-06Clinical Trial Update: Interleukin-15 and -21 Armored Glypican-3-specific Chimeric Antigen Receptor Expressed in T Cells for Pediatric Solid Tumors [Phase 1]
Phase 1 trial evaluating an IL-15/IL-21 armored GPC3-targeted CAR-T cell therapy for pediatric solid tumors is currently recruiting.
-
CLINICAL_TRIALS research · 2026-03-18Clinical Trial Update: Dose Escalation Study of CLR 131 in Pediatric Relapsed/Refractory Malignant Tumors Including Neuroblastoma and Sarcomas [Phase 1]
Phase 1 dose-escalation study of CLR-131 in children with relapsed or refractory malignant tumors, including neuroblastoma and sarcomas, cur…
-
CLINICAL_TRIALS trial_result · 2026-03-16Clinical Trial Update: FGFR4 Chimeric Antigen Receptor (CAR) T Cells in Children and Young Adults With Recurrent or Refractory Rhabdomyosarcoma [Phase 1]
This is a Phase 1 clinical trial evaluating FGFR4 CAR T cells in children and young adults with recurrent or refractory rhabdomyosarcoma; th…
-
CLINICAL_TRIALS trial_result · 2026-03-16Clinical Trial Update: Vincristine and Temozolomide in Combination With PEN-866 for Adolescents and Young Adults With Relapsed or Refractory Solid Tumors [Phase 1, Phase 2]
An NCI-sponsored Phase 1/2 trial of vincristine and temozolomide with PEN-866 in adolescents and young adults with relapsed or refractory so…
-
CLINICAL_TRIALS research · 2026-03-13Clinical Trial Update: Comparing Carbon Ion Therapy, Surgery, and Proton Therapy for Management of Pelvic Sarcomas Involving the Bone
A Mayo Clinic-sponsored trial is evaluating carbon ion therapy, surgery, and proton therapy for pelvic sarcomas involving bone. Recruitment …
-
CLINICAL_TRIALS research · 2026-03-12Clinical Trial Update: A Study Comparing Higher Dose Chemotherapy Over a Shorter Amount of Time to Lower Dose Chemotherapy Plus Maintenance Over a Longer Amount of Time in Patients With Newly Diagnosed Intermediate-Risk Rhabdomyosarcoma (IR RMS) [Phase 3]
A Phase 3 clinical trial compares higher-dose chemotherapy over a shorter period with lower-dose chemotherapy plus maintenance over a longer…
-
CLINICAL_TRIALS research · 2026-03-11Clinical Trial Update: Alpha/Beta T and B Cell Depletion With Zoledronic Acid for Solid Tumors [Phase 1, Phase 2]
Phase 1/2 clinical trial evaluating alpha/beta T and B cell depletion with zoledronic acid for solid tumors; recruitment is ongoing.
-
CLINICAL_TRIALS trial_result · 2026-03-06Clinical Trial Update: Interleukin-15 Armored Glypican 3-specific Chimeric Antigen Receptor Expressed in Autologous T Cells for Solid Tumors [Phase 1]
Phase 1 trial evaluating IL-15 armored glypican-3–specific CAR-T cells for solid tumors, including hepatocellular carcinoma and several pedi…
-
CLINICAL_TRIALS research · 2026-03-03Clinical Trial Update: Liposomal Irinotecan, Vincristine, Temozolomide, and Anlotinib for R/R Pediatric Solid Tumors [Phase 2]
This clinical trial update outlines a Phase 2 study evaluating a combination of liposomal irinotecan, vincristine, temozolomide, and anlotin…
-
CLINICAL_TRIALS research · 2026-02-19Clinical Trial Update: Phase 1/2 Trial to Evaluate the Safety and Efficacy of PEEL-224 in Combination With Vincristine and Temozolomide in Adolescents and Young Adults With Relapsed or Refractory Sarcomas [Phase 1, Phase 2]
A Phase 1/2 clinical trial is evaluating the safety and potential efficacy of PEEL-224 in combination with vincristine and temozolomide in a…
-
CLINICAL_TRIALS research · 2026-02-17Clinical Trial Update: Immunotherapy for Solid Tumor Malignancies in Pediatrics Using Interleukin-15 and -21 Armored Glypican-3-specific Chimeric Antigen Receptor T Cells [Phase 1]
Phase 1 pediatric trial of interleukin-15 and interleukin-21 armored glypican-3–specific CAR T cells for solid tumors, including liver-origi…
-
CLINICAL_TRIALS research · 2026-02-17Clinical Trial Update: A Study to Compare Early Use of Vinorelbine and Maintenance Therapy for Patients With High Risk Rhabdomyosarcoma [Phase 3]
Phase 3 study by the Children's Oncology Group comparing early use of vinorelbine and maintenance therapy for high-risk rhabdomyosarcoma is …
-
CLINICAL_TRIALS research · 2026-02-09Clinical Trial Update: Hypofractionated Radiation in Combination With B7-H3-CAR T Cells for Pediatric Patients With Relapsed/Refractory Sarcomas [Phase 1]
Phase 1 clinical trial in pediatric relapsed/refractory sarcomas evaluating hypofractionated radiation in combination with B7-H3-CAR T cells…
-
CLINICAL_TRIALS trial_result · 2026-02-06Clinical Trial Update: A Study of CD45RA+ Depleted Haploidentical Stem Cell Transplantation in Children With Relapsed or Refractory Solid Tumors and Lymphomas [Phase 1]
Phase 1 study evaluating CD45RA+ depleted haploidentical stem cell transplantation in children with relapsed or refractory solid tumors and …